Explore Watchlists Pricing

AbbVie Inc. (ABBV) Balance sheet

Market cap

$349B

P/E ratio

83.6x

Summary Financials

Income statement Balance sheet Cash flow Other

	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Cash and cash equivalents	9,595	8,348	8,399	5,100	9,303	7,289	39,924	8,449	9,746	9,201	12,814	5,524	5,229
Total cash & short-term investments	9,595	8,348	8,399	5,100	9,303	7,289	39,924	8,449	9,746	9,201	12,814	5,524	5,229
Accounts receivable, net	-	-	-	-	-	5,384	5,428	8,822	9,977	11,254	11,155	10,919	12,589
Inventories	1,150	1,124	1,719	1,444	1,605	1,605	1,813	3,310	3,128	3,579	4,099	4,181	4,951
Total current assets	17,848	16,088	16,314	16,187	21,223	16,945	49,519	24,173	27,928	28,463	33,002	25,582	29,062
Property, plant and equipment, net	2,298	2,485	2,565	2,604	2,803	2,883	2,962	5,248	5,110	4,935	4,989	5,134	5,628
Marketable securities, non-current	118	92	145	1,783	2,090	1,420	93	293	277	241	304	279	268
Total non-current assets	-	-	-	-	-	-	2,962	5,248	5,110	4,935	4,989	5,134	5,628
Total assets	29,198	27,547	53,050	66,099	70,786	59,352	89,115	150,565	146,529	138,805	134,711	135,161	133,960
Total current liabilities	6,879	11,400	10,894	9,781	16,641	17,239	15,585	28,661	35,194	29,538	37,841	38,749	43,289
Retained earnings	1,567	535	2,248	4,378	5,459	3,368	4,717	1,055	3,127	4,784	-1,000	-7,900	-15,493
Stockholders' equity	4,492	1,742	3,945	4,636	5,097	-8,446	-8,172	13,097	15,436	17,287	10,397	3,364	-3,228